Funded Tech Companies

NexGenix Pharmaceuticals

NexGenix Pharmaceuticals, operating out of New York, received equity investments through private investors.

Company Overview

Company Name
NexGenix Pharmaceuticals
Company Status
Private & Independent
Funding Rounds

Contact Information

Mailing Address
30 East 85th St. 3B
New York, NY 10028
USA
Email Address

Company Background Information

Overview
NexGenix Pharmaceuticals is a US-based company focused on drug development for Neurofibromatosis Types 1 and 2 and related sporadic tumors. Neurofibromatosis (NF) is an autosomal dominant genetic disorder characterized by the development of tumors along nerves.
Profile
NexGenix Pharmaceuticals LinkedIn Company Profile
Social Media
NexGenix Pharmaceuticals Company Twitter Account
Company News
NexGenix Pharmaceuticals News
Facebook
NexGenix Pharmaceuticals on Facebook
YouTube
NexGenix Pharmaceuticals on YouTube
Last Transaction
7/16/2007

Financing History

Date
Type
Amount
Venture Equity
$3,900,000


Management Team

Title
Name
Email & Social
Chief Executive Officer
Allan Rubenstein
  Allan Rubenstein LinkedIn Profile  Allan Rubenstein Twitter Account  Allan Rubenstein News  Allan Rubenstein on Facebook
VP - R & D
Ruihong Chen
  Ruihong Chen LinkedIn Profile  Ruihong Chen Twitter Account  Ruihong Chen News  Ruihong Chen on Facebook


Company Investors

     

     

     

    Browse more funded tech companies:

    Nexgenia | NexGenT

     

    Share this article

     


    About Our Venture Capital Database

    This venture capital transaction data comes via a partnership with VentureDeal.com, a leading supplier of venture capital funding data.

     


    Additional Resources for Entrepreneurs

    Lists of Venture Capital and Private Equity Firms

    Franchise Opportunities

    Contributors

    Business Glossary